It is overexpressed in various malignant tumors such as breast cancer, liver cancer, and pancreatic cancer [35, 36], which is consistent with the findings in this study that the expression of c-MYC is significantly upregulated in both gastric cancer tissue specimens and cell lines and is consistent with the results related to the degree of invasion of gastric cancer. This evidence concerns the gene MYC and breast cancer.